Atlanta Consulting Group Advisors LLC Makes New $505,000 Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

by · The Cerbat Gem

Atlanta Consulting Group Advisors LLC acquired a new position in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 1,028 shares of the medical equipment provider’s stock, valued at approximately $505,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. International Assets Investment Management LLC boosted its position in shares of Intuitive Surgical by 49,383.6% during the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after acquiring an additional 1,088,415 shares during the last quarter. Capital Research Global Investors bought a new position in shares of Intuitive Surgical during the 1st quarter valued at approximately $374,390,000. Strategic Financial Concepts LLC raised its holdings in Intuitive Surgical by 40,221.4% during the 2nd quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider’s stock valued at $1,184,000 after buying an additional 265,461 shares during the period. GQG Partners LLC bought a new stake in Intuitive Surgical in the first quarter worth $99,523,000. Finally, Canada Pension Plan Investment Board boosted its stake in Intuitive Surgical by 36.4% during the first quarter. Canada Pension Plan Investment Board now owns 807,780 shares of the medical equipment provider’s stock worth $322,377,000 after buying an additional 215,444 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, insider Jamie Samath sold 269 shares of the business’s stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $539.89, for a total transaction of $145,230.41. Following the sale, the insider now owns 8,757 shares in the company, valued at approximately $4,727,816.73. The trade was a 2.98 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Henry L. Charlton sold 40,243 shares of the firm’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the transaction, the senior vice president now owns 3,001 shares of the company’s stock, valued at approximately $1,461,006.84. The trade was a 93.06 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 91,178 shares of company stock worth $45,897,071. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $527.61 on Monday. The firm has a market capitalization of $187.92 billion, a P/E ratio of 84.82, a P/E/G ratio of 5.19 and a beta of 1.39. The business’s 50-day moving average is $499.29 and its 200 day moving average is $458.50. Intuitive Surgical, Inc. has a 1 year low of $295.02 and a 1 year high of $544.38.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the stock. Citigroup raised their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research note on Friday, October 18th. Wells Fargo & Company raised their price target on Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a research note on Friday, October 18th. Mizuho upped their price objective on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Finally, BTIG Research set a $535.00 target price on Intuitive Surgical in a research report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $524.61.

Get Our Latest Stock Analysis on Intuitive Surgical

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Stories

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).